Merck has announced that the European Commission has approved an update to the Erbitux (cetuximab) EU label, extending its ...
Eisai and Biogen have announced that the U.S. Food and Drug Administration has approved a supplemental biologics licence application for a once weekly subcutaneous initiation dose ...
The Scottish Medicines Consortium has recommended Astellas’s VEOZA (fezolinetant) 45 mg once daily for the treatment of ...
Compass Pathways has announced six‑month results from its second phase 3 trial of COMP360, its synthetic formulation of ...
An update on the first clinical trial evaluating a pluripotent stem cell‑derived neural stem cell therapy for Huntington’s ...
Grünenthal has received Orphan Drug and Rare Pediatric Disease designations from the US Food and Drug Administration for ...
Novartis has secured European Commission approval for Itvisma for the treatment of children aged two years and older, as well ...
Applications have opened for the ninth cohort of KQ Labs, the national accelerator for data‑driven health start‑ups delivered ...
AlzeCure Pharma has signed an out‑licensing and collaboration agreement with Danish biotech QuantumCell ApS, granting global ...
The Government’s recently announced NHS Modernisation Bill represents one of the most consequential attempts to reshape the ...
Last year I engineered an advanced agentic AI pharma strategy development application. One year later, after many ...
How better data sharing could save lives in the UK ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results